Initial indicators of the public health impacts of non-medical cannabis legalization in Canada.
作者信息
Fischer Benedikt, Lee Angelica, O'Keefe-Markman Caroline, Hall Wayne
机构信息
Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland 1023, New Zealand.
Centre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Suite 2400 515 W. Hastings Street, Vancouver, British Columbia, V6B 5K3, Canada.
出版信息
EClinicalMedicine. 2020 Mar 20;20:100294. doi: 10.1016/j.eclinm.2020.100294. eCollection 2020 Mar.
Abstract
摘要
相似文献
1
Initial indicators of the public health impacts of non-medical cannabis legalization in Canada.加拿大非医用大麻合法化对公共卫生影响的初步指标。
EClinicalMedicine. 2020 Mar 20;20:100294. doi: 10.1016/j.eclinm.2020.100294. eCollection 2020 Mar.
2
Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.评估加拿大大麻合法化对公共卫生的影响：监测和评估的“指标”核心结果指标。
J Public Health (Oxf). 2019 Jun 1;41(2):412-421. doi: 10.1093/pubmed/fdy090.
3
The Challenges of Projecting the Public Health Impacts of Marijuana Legalization in Canada Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts".加拿大大麻合法化对公共卫生影响预测的挑战 评“在加拿大使大麻合法化和监管：对潜在经济、社会和健康影响的回顾”。
Int J Health Policy Manag. 2017 May 1;6(5):285-287. doi: 10.15171/ijhpm.2016.124.
4
On the use of digital technologies to reduce the public health impacts of cannabis legalization in Canada.利用数字技术减少加拿大大麻合法化对公共健康的影响。
Can J Public Health. 2018 Dec;109(5-6):748-751. doi: 10.17269/s41997-018-0117-7. Epub 2018 Aug 10.
5
From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada.从厨师帽到大麻烟：加拿大全国范围内大麻合法化面临的两大挑战。
Int J Drug Policy. 2017 Apr;42:97-101. doi: 10.1016/j.drugpo.2017.03.002. Epub 2017 Apr 1.
6
A missed opportunity? Cannabis legalization and reparations in Canada.错失的机会？加拿大的大麻合法化与赔偿
Can J Public Health. 2018 Dec;109(5-6):745-747. doi: 10.17269/s41997-018-0121-y. Epub 2018 Sep 17.
7
A critique of cannabis legalization proposals in Canada.对加拿大大麻合法化提案的批判。
Int J Drug Policy. 2016 Aug;34:5-10. doi: 10.1016/j.drugpo.2016.05.002. Epub 2016 May 13.
8
Protecting the public from exposure to secondhand cannabis smoke and vapour following legalization.在大麻合法化后，保护公众免受二手大麻烟雾和蒸气的暴露。
Can J Public Health. 2018 Apr;109(2):223-226. doi: 10.17269/s41997-018-0054-5. Epub 2018 Apr 19.
9
"Where does the high road lead?" Potential implications of cannabis legalization for pediatric injuries in Canada.“高路将通往何方？”加拿大大麻合法化对儿科伤害的潜在影响。
Can J Public Health. 2018 Dec;109(5-6):752-755. doi: 10.17269/s41997-018-0137-3. Epub 2018 Sep 27.
10
Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts.在加拿大使大麻合法化和监管大麻：对潜在经济、社会和健康影响的审查。
Int J Health Policy Manag. 2016 Aug 1;5(8):453-456. doi: 10.15171/ijhpm.2016.63.
引用本文的文献
1
Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis.在药物中毒危机期间，使用未经监管的阿片类药物的人使用大麻来控制阿片类药物的渴望。
Int J Drug Policy. 2023 Sep;119:104113. doi: 10.1016/j.drugpo.2023.104113. Epub 2023 Jul 21.
2
Cannabis Consumers' View of Regulated Access to Recreational Cannabis: A Multisite Survey in Switzerland.大麻消费者对娱乐用大麻管制准入的看法：瑞士多地点调查。
Eur Addict Res. 2023;29(3):213-221. doi: 10.1159/000530194. Epub 2023 May 16.
3
Prevalence and association of non-medical cannabis use with post-procedural healthcare utilisation in patients undergoing surgery or interventional procedures: a retrospective cohort study.接受手术或介入治疗的患者中，非医用大麻使用的患病率及其与术后医疗保健利用的关联：一项回顾性队列研究。
EClinicalMedicine. 2023 Jan 31;57:101831. doi: 10.1016/j.eclinm.2023.101831. eCollection 2023 Mar.
4
Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source.休闲大麻合法化：从非法来源转向合法来源的促进因素和障碍。
Prev Med Rep. 2021 Nov 16;24:101639. doi: 10.1016/j.pmedr.2021.101639. eCollection 2021 Dec.
5
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.加拿大合法化前后选择的大麻使用和供应指标概述。
Subst Abuse Treat Prev Policy. 2021 Oct 7;16(1):77. doi: 10.1186/s13011-021-00405-7.
6
The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients.非医用大麻合法化及其他暴露因素对纵向大麻研究中留存率的影响：一项对加拿大医用大麻患者前瞻性研究的生存分析
J Cannabis Res. 2021 Jul 28;3(1):34. doi: 10.1186/s42238-021-00089-7.
7
Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it.未知的大麻和烟草共同使用对人群的危害：不测量，就无法管理。
Addiction. 2021 Jul;116(7):1622-1630. doi: 10.1111/add.15290. Epub 2020 Nov 20.
8
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.面对新西兰大麻使用和供应合法化的选择：相关证据、概念和考虑因素概述。
Drug Alcohol Rev. 2020 Jul;39(5):555-567. doi: 10.1111/dar.13087. Epub 2020 May 20.
本文引用的文献
1
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.将大麻的生产和销售合法化用于医疗和娱乐用途对公共卫生的影响。
Lancet. 2019 Oct 26;394(10208):1580-1590. doi: 10.1016/S0140-6736(19)31789-1. Epub 2019 Oct 23.
2
Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis.大麻政策的自由化是否会影响青少年和年轻人的使用水平？一项系统评价和荟萃分析。
BMJ Open. 2019 Jul 10;9(7):e025880. doi: 10.1136/bmjopen-2018-025880.
3
Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.评估加拿大大麻合法化对公共卫生的影响：监测和评估的“指标”核心结果指标。
J Public Health (Oxf). 2019 Jun 1;41(2):412-421. doi: 10.1093/pubmed/fdy090.
Zotero 插件